CD274 and breast cancer: Based on the mass spectrometry datasets of tumors and non-malignant tissues from breast cancer patients, we found higher levels of PD-L1 glycosylation and phosphorylation in tumors than that in non-malignant tissues30,31 (Fig. 1b, c).